Arrowstreet Capital, Limited Partnership Emergent Bio Solutions Inc. Transaction History

Arrowstreet Capital, Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $437,211 - $695,680	15,945 New	15,945 $495,000
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $3.91 Million - $5.37 Million	-81,093 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $1.46 Million - $1.93 Million	26,293 Added 47.98%	81,093 $4.81 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $1.44 Million - $1.84 Million	27,608 Added 101.53%	54,800 $3.61 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $1.43 Million - $1.65 Million	-29,569 Reduced 52.09%	27,192 $1.37 Million
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $2.52 Million - $3.09 Million	56,761 New	56,761 $2.99 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $515M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.